首页> 外文期刊>Analytical methods >Validated voltammetric determination of olmesartan medoxomil: Method development and electrochemical behaviors investigation
【24h】

Validated voltammetric determination of olmesartan medoxomil: Method development and electrochemical behaviors investigation

机译:验证的伏安法测定奥美沙坦酯:方法开发和电化学行为研究

获取原文
           

摘要

In this study, a sensitive, simple and rapid voltammetric method was developed and validated for the determination of olmesartan medoxomil in pharmaceutical formulations. The experimental and instrumental parameters affecting the peak current of olmesartan medoxomil were investigated and optimized. For this purpose, square-wave voltammetry at a hanging mercury drop electrode in electrolytes of different pH and buffers was tried. Olmesartan medoxomil showed a reduction peak between the pH range 5.0 to 8.0, and phosphate buffer at pH 6.5 was selected as the optimum electrolyte condition for analysis, since well-defined peaks were obtained. The following instrumental parameters were employed for analytical application: frequency 50 Hz, scan increment 5 mV and pulse amplitude 25 mV. In these optimum conditions highly sensitive measurements of olmesartan medoxomil were achieved. Validation parameters such as linearity, sensitivity, selectivity, precision, accuracy, ruggedness and robustness for the developed method were evaluated. The square-wave voltammetric peak currents increased linearly with the corresponding olmesartan medoxomil concentration in the range of 1.00a€“14.56 ??g mLa?’1 (r = 0.9983) with a detection limit of 0.50 ??g mLa?’1 and limit of quantitation of 1.00 ??g mLa?’1. The developed method was successfully used for determination of olmesartan medoxomil in tablets and the data were compared with ones obtained from the capillary electrophoresis method given in the literature. Possible interferences by several substances usually present in the pharmaceutical formulations have been also evaluated. The percentage recoveries varied from 98.20 to 100.26%. It has been shown that olmesartan medoxomil could be directly determined in the presence of excipients from tablets by the developed method without the necessity for prior extraction or interaction with any reagent during the analysis.
机译:在这项研究中,开发了一种灵敏,简单而快速的伏安法,并已验证了该方法可用于测定药物制剂中的奥美沙坦美多美。研究和优化了影响奥美沙坦美多西莫峰值电流的实验和仪器参数。为此,尝试在悬挂的汞滴电极上在不同pH和缓冲液的电解质中进行方波伏安法。 Olmesartan medoxomil在pH范围为5.0到8.0之间显示一个还原峰,并且由于获得了明确定义的峰,因此选择pH值为6.5的磷酸盐缓冲液作为最佳电解质分析条件。以下仪器参数用于分析应用:频率50 Hz,扫描增量5 mV和脉冲幅度25 mV。在这些最佳条件下,可实现奥美沙坦美多美的高度灵敏测量。评估了所开发方法的验证参数,例如线性,灵敏度,选择性,精度,准确性,坚固性和鲁棒性。方波伏安峰值电流随相应的奥美沙坦medoxomil浓度在1.00a?14.56?g mLa?'1(r = 0.9983)的范围内线性增加,检测极限为0.50?g gmLa?'1和定量限为1.00 ?? g mLa?'1。所开发的方法已成功用于片剂中奥美沙坦的测定,并将数据与文献中的毛细管电泳方法进行了比较。还评估了通常存在于药物制剂中的几种物质可能产生的干扰。回收率从98.20%到100.26%。已经显示,通过所开发的方法可以在片剂中存在赋形剂的情况下直接测定奥美沙坦美多美,而无需在分析过程中预先提取或与任何试剂相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号